Samraat S. Raha - 12 Mar 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
President and CEO, Director
Signature
By: Justin Hunter For: Samraat S. Raha
Issuer symbol
MYGN
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 17:05:26 UTC
Previous filing
09 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Raha Samraat S. President and CEO, Director 322 NORTH 2200 WEST, SALT LAKE CITY By: Justin Hunter For: Samraat S. Raha 16 Mar 2026 0001738340

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award +618,557 +125% $0.000000* 1,111,661 12 Mar 2026 Direct F1
transaction MYGN Common Stock Tax liability -36,304 -3.3% $4.66* 1,075,357 13 Mar 2026 Direct F2
transaction MYGN Common Stock Tax liability -10,816 -1% $4.66* 1,064,541 14 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.
F2 Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.